SRZN - Surrozen, Inc./DE

QQQ $ 617.50 $ 6.52 (1.07 %)

DIA $ 472.45 $ 4.92 (1.05 %)

SPY $ 677.25 $ 5.49 (0.82 %)

TLT $ 91.47 $ 0.04 (0.04 %)

GLD $ 378.59 $ -1.27 (-0.34 %)

Previous Close

$ 13.75

Open

$ 13.71

Bid

$ 13.51 x 7

Ask

$ 13.87 x 13

Day's Range

$ 13.69 - $ 13.80

52 Week Range

$ 5.90 - $ 18.17

Volume

6,341

Average Volume

Market Cap

117.74M

Beta (5Y Monthly)

$ 0.46

PE Ratio (TTM)

$ 13.75

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2025	06-30-2025	10-Q
2	05-09-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K
4	11-06-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-08-2024	03-31-2024	10-Q
7	04-10-2024	12-31-2023	10-K
8	11-08-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	03-31-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-11-2022	03-31-2022	10-Q
15	03-28-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-06-2021	06-30-2021	10-Q
18	05-24-2021	03-31-2021	10-Q
19	03-31-2021	12-31-2020	10-K
20	01-04-2021	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Surrozen Announces Termination Of Collabor...
10/17/2025 20:25:32

On October 14, 2025, Surrozen, Inc. (the "Company") received notice from TCGFB, Inc. ("TCGFB") that TCGFB has e...

Surrozen Files For Common Stock Offering O...
08/29/2025 21:03:12

-SEC Filing

Surrozen Q2 EPS $2.55 Beats $(1.11) Estima...
08/08/2025 20:09:26

Surrozen (NASDAQ:SRZN) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $(1.11) by 3...

Surrozen Granted US Patent To Antibody-Bas...
05/14/2025 12:38:28

Newly granted patent is part of the expanding intellectual property portfolio directed to:-generating novel and selective Wnt s...

HC Wainwright & Co. Reiterates Buy on Surr...
05/12/2025 10:59:22

HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and maintains $32 price target.

Surrozen Q1 EPS $(7.43) Misses $(1.78) Est...
05/09/2025 20:07:59

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(1.78) by...

HC Wainwright & Co. Reiterates Buy on Surr...
04/02/2025 11:12:51

HC Wainwright & Co. analyst Matthew Caufield reiterates Surrozen (NASDAQ:SRZN) with a Buy and maintains $32 price target.

Surrozen FY 2024 GAAP EPS $(21.67) Misses ...
03/31/2025 20:15:13

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(21.67) per share which missed the analyst consensus estimate of $(9.04) b...

this-worthington-enterprises-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday

This Worthington Enterprises Analyst Begin...
01/30/2025 14:15:24

HC Wainwright & Co. Initiates Coverage On ...
01/30/2025 11:33:35

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on Surrozen (NASDAQ:SRZN) with a Buy rating and announce...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
01/16/2025 21:05:59

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
01/03/2025 21:05:52

Guggenheim Upgrades Surrozen to Buy, Maint...
01/03/2025 16:01:54

Guggenheim analyst Yatin Suneja upgrades Surrozen (NASDAQ:SRZN) from Neutral to Buy and maintains the price target from $45 ...

Surrozen Q3 EPS $(0.44) Beats $(2.46) Esti...
11/06/2024 14:02:23

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(2.46) by 8...

Surrozen Q3 EPS $(0.44) Beats $(2.46) Esti...
11/06/2024 14:01:35

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(2.46) by 8...

Surrozen And TCGFB Announce Strategic Rese...
11/04/2024 13:47:29

Surrozen, Inc. ("Surrozen" or the "Company") (NASDAQ:SRZN), a company pioneering targeted therapeutics that sel...

Surrozen Earns $10M Milestone Payment As B...
09/24/2024 12:36:14

Surrozen Q2 2024 Adj EPS $(7.99) Misses $(...
08/12/2024 20:22:56

Surrozen (NASDAQ:SRZN) reported quarterly losses of $(7.99) per share which missed the analyst consensus estimate of $(2.79) by...

Surrozen Publishes Study In 'eLife' Highli...
06/12/2024 12:32:38

Targeted protein degradation (TPD*) technologies have demonstrated the potential to produce novel treatment approaches Surrozen...

Surrozen Presents Preliminary Results Of P...
06/10/2024 12:30:50

SZN-043 is a novel biotherapeutic shown to potentiate Wnt signaling and induce proliferation of hepatocytes in preclinical mode...